Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2015

01-06-2015 | Erratum

Erratum to: Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol

Authors: Peter Declercq, Gunter De Win, Frank Van der Aa, Elodie Beels, Lorenz Van der Linden, Hendrik Van Poppel, Ludo Willems, Isabel Spriet

Published in: International Journal of Clinical Pharmacy | Issue 3/2015

Login to get access

Excerpt

Unfortunately, the first and the last name of the fourth, seventh and eighth co-authors were published incorrectly in the original publication. The corrected author names are given in the erratum. …
Metadata
Title
Erratum to: Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol
Authors
Peter Declercq
Gunter De Win
Frank Van der Aa
Elodie Beels
Lorenz Van der Linden
Hendrik Van Poppel
Ludo Willems
Isabel Spriet
Publication date
01-06-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0098-z

Other articles of this Issue 3/2015

International Journal of Clinical Pharmacy 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine